scispace - formally typeset
Open AccessJournal ArticleDOI

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

TLDR
Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection.
About
This article is published in The Lancet.The article was published on 2020-01-30 and is currently open access. It has received 16282 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.

TL;DR: IL‐6 and d‐D were closely related to the occurrence of severe CO VID‐19 in the adult patients, and their combined detection had the highest specificity and sensitivity for early prediction of the severity of COVID‐19 patients, which has important clinical value.
Journal ArticleDOI

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.

TL;DR: It is shown that SARS-Cov-2 selectively induces a high level of IL-6 and results in the exhaustion of lymphocytes, and the current evidence indicates that tocilizumab, an IL- 6 inhibitor, is relatively effective and safe.
Posted ContentDOI

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

TL;DR: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia.
Journal ArticleDOI

Laboratory abnormalities in patients with COVID-2019 infection.

TL;DR: The evidence that laboratory criteria for diagnosing DIC are present in nearly three-fourths of patients who died underscores the critical role of these tests in this and other clinical settings, thus suggesting that their assessment shall be considered a routine part of COVID-19 patient monitoring.
Journal ArticleDOI

Can we contain the COVID-19 outbreak with the same measures as for SARS?

TL;DR: COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread, but even if traditional public health measures are not able to fully contain the outbreak of CO VID-19, they will still be effective in reducing peak incidence and global deaths.
References
More filters
Journal ArticleDOI

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

TL;DR: The clinical picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.
Journal ArticleDOI

Origin and evolution of pathogenic coronaviruses

TL;DR: The viral factors that enabled the emergence of diseases such as severe acute respiratory syndrome and Middle East respiratory syndrome are explored and the diversity and potential of bat-borne coronaviruses are highlighted.
Related Papers (5)